Showing the single result

  • Ceritinib 150 mg

    Ceritinib 150 mg

    0 out of 5
    $380

    SPEXIB (Ceritinib) is a targeted therapy that targets and binds to the tyrosine kinase receptors and inhibits ALK, insulin-like growth factor 1 receptor (IGF-1R), insulin receptor (InsR), and ROS1on the surface of the cell. By binding to these receptors ceritinib blocks an important pathway that promotes cell division.

    Select optionsDone This product has multiple variants. The options may be chosen on the product page

End of content

End of content